RecruitingNCT05800925
Triage Survey for Psychiatry Research Eligibility
Sponsor
Adams Clinical
Enrollment
20,000 participants
Start Date
Dec 21, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
- Participant is at least 18 years old.
Exclusion Criteria6
- Participant is pregnant, breast-feeding, or planning to become pregnant.
- History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
- Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on C-SSRS questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
- Moderate or severe substance use disorder within 90 days prior to screen, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
- Any condition that in the investigator's opinion makes a participant unsuitable for the study.
- Currently employed by Adams Clinical or a first-degree relative of an employee.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERSurvey
Participants will be surveyed on demographics, medical history, and current psychiatric symptoms. Vital signs, urine drug screens, and urine pregnancy tests may be collected.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05800925
Related Trials
Neural Correlates of Stress and Perceived Control in Adolescent Depression
NCT047885241 location
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
NCT0670547841 locations
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
NCT069345251 location
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
NCT0748965112 locations
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
NCT0759268918 locations